DeckTherapeutics announces the formation of Scientific Advisory Board

Written By Joe Jensen

DeckTherapeutics today announced the formation of a Scientific Advisory Board comprised of some of the world’s foremost clinician scientists, practitioners and clinical trial experts, in the area of treating hypoxic-ischemic brain injuries.

Joe Jensen
Previous

DeckTherapeutics announces grant of patent
Next

DeckTherapeutics participates in Biotech Showcase